venetoclax,ibrutinib
roche,abbvie,Janssen
['venetoclax', 'cll']
fabulous talk by dr. thijssen on venetoclax resistance in pts w/cll - w/potential opportunities to use nfkb &amp; mcl1 to identify which pts are most likely to respond to re-tx w/ven at time of progression after prior time-limited tx w/ven. #eha22 #cll
Assistant Professor of Medicine in CLL at Mayo Clinic and lifelong learner with a passion for education, hiking, and cooking. Views expressed are my own.